CERE - Cerevel Therapeutics Holdings Inc. (CERE) CEO Tony Coles on Q4 2021 Results - Earnings Call Transcript

Cerevel Therapeutics Holdings, Inc. (CERE) Q4 2021 Earnings Conference Call March 1, 2022 8:00 AM ET Company Participants Matthew Calistri - Vice President of Investor Relations Tony Coles - Chairperson & Chief Executive Officer Ray Sanchez - Chief Medical Officer John Renger - Chief Scientific Officer Mark Bodenrader - Interim Chief Financial Officer Conference Call Participants Michael Yee - Jefferies Matthew Harrison - Morgan Stanley Paul Matteis - Stifel Douglas Tsao - H.C. Wainwright Omari Baruti - Goldman Sachs Tiffany Sun - JPMorgan Presentation Operator Good morning. Welcome to the Cerevel Therapeutics Fourth Quarter and Full Year 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, you will have the opportunity to ask questions during the Q&A portion of the call. Please note that this call maybe recorded. I will now hand the call over to Matt Calistri, Vice President, Corporate Strategy and

For further details see:

Cerevel Therapeutics Holdings, Inc. (CERE) CEO Tony Coles on Q4 2021 Results - Earnings Call Transcript